• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌与骨转移:中轴骨骼磁共振成像结果与骨相关事件及生存情况的关联

Breast cancer and bone metastases: the association of axial skeleton MRI findings with skeletal-related events and survival.

作者信息

van der Pol Christian B, Schweitzer Mark E, Di Primio Gina, Sampaio Marcos L, Kielar Ania, Clemons Mark, Jaberi Arash

机构信息

Department of Diagnostic Imaging, The Ottawa Hospital, 1053 Carling Avenue, Ottawa, ON, K1Y 4E9, Canada,

出版信息

Breast Cancer Res Treat. 2014 Aug;146(3):583-9. doi: 10.1007/s10549-014-3046-z. Epub 2014 Jul 10.

DOI:10.1007/s10549-014-3046-z
PMID:25007963
Abstract

The purpose of this study was to determine if bone metastasis characteristics on axial skeleton MRI are associated with either skeletal-related events (SREs) or survival in breast cancer patients. A retrospective review was performed on 247 breast cancer patients with bone metastases identified on axial skeleton MRI. MRI studies were reviewed for metastases T1 signal, signal uniformity, complete vertebral metastatic marrow replacement, metastases quantity, and distribution. Odds ratio (OR) and hazard ratios (HR) were calculated, with 95 % confidence intervals (95 % CI), to determine association with either future SREs or survival. At the time of analysis, 174 (70 %) patients had developed SREs and 176 (71 %) patients were dead. Features of skeletal metastases associated with SREs included the presence of complete metastatic marrow replacement within any vertebra; OR 2.363 (95 % CI 1.240-4.504, P = 0.0090), and more widely distributed metastases; OR 1.239 (95 % CI 1.070-1.435, P = 0.0040). Features associated with shorter survival included the presence of complete metastatic marrow replacement within any vertebra; HR 1.500 (95 % CI 1.105-2.036, P = 0.0093), and more widely distributed metastases; HR 1.141 (95 % CI 1.047-1.243, P = 0.0027). Metastases T1 signal, signal uniformity, and surprisingly quantity were not associated with SREs or survival. Axial skeleton MRI was able to identify characteristics predictive of future SREs and survival. These characteristics could be used for risk stratification for future trials if prospectively validated.

摘要

本研究的目的是确定乳腺癌患者轴向骨骼磁共振成像(MRI)上的骨转移特征是否与骨相关事件(SREs)或生存率相关。对247例经轴向骨骼MRI确诊为骨转移的乳腺癌患者进行了回顾性研究。对MRI研究进行了转移灶T1信号、信号均匀性、椎体转移性骨髓完全替代、转移灶数量和分布的评估。计算比值比(OR)和风险比(HR)以及95%置信区间(95%CI),以确定与未来SREs或生存率的相关性。在分析时,174例(70%)患者发生了SREs,176例(71%)患者死亡。与SREs相关的骨转移特征包括任何椎体存在转移性骨髓完全替代;OR为2.363(95%CI 1.240 - 4.504,P = 0.0090),以及转移灶分布更广泛;OR为1.239(95%CI 1.070 - 1.435,P = 0.0040)。与生存期较短相关的特征包括任何椎体存在转移性骨髓完全替代;HR为1.500(95%CI 1.105 - 2.036,P = 0.0093),以及转移灶分布更广泛;HR为1.141(95%CI 1.047 - 1.243,P = 0.0027)。转移灶T1信号、信号均匀性以及出人意料的转移灶数量与SREs或生存率无关。轴向骨骼MRI能够识别预测未来SREs和生存率的特征。如果经过前瞻性验证,这些特征可用于未来试验的风险分层。

相似文献

1
Breast cancer and bone metastases: the association of axial skeleton MRI findings with skeletal-related events and survival.乳腺癌与骨转移:中轴骨骼磁共振成像结果与骨相关事件及生存情况的关联
Breast Cancer Res Treat. 2014 Aug;146(3):583-9. doi: 10.1007/s10549-014-3046-z. Epub 2014 Jul 10.
2
Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999-2007).丹麦(1999-2007 年)基于人群的队列研究:乳腺癌伴骨转移和骨骼相关事件患者的生存情况。
Breast Cancer Res Treat. 2011 Sep;129(2):495-503. doi: 10.1007/s10549-011-1475-5. Epub 2011 Apr 2.
3
Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumors of the axial skeleton.磁共振成像与骨髓闪烁显像在轴向骨骼转移性实体瘤患者中的比较诊断价值及治疗相关性
Eur J Radiol. 2002 Sep;43(3):256-61. doi: 10.1016/s0720-048x(01)00477-6.
4
[Prognostic factors and analyses of different therapeutic strategies in HR+ breast cancer patients with bone-only metastases].[HR+ 仅骨转移乳腺癌患者的预后因素及不同治疗策略分析]
Zhonghua Yi Xue Za Zhi. 2012 Dec 11;92(46):3279-82.
5
Prognostic Factors in Patients with Metastatic Breast Cancer with Bone-Only Metastases.仅有骨转移的转移性乳腺癌患者的预后因素。
Oncologist. 2018 Nov;23(11):1282-1288. doi: 10.1634/theoncologist.2018-0085. Epub 2018 Aug 17.
6
Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice.对典型临床实践中所见的乳腺癌骨转移患者骨骼并发症对总医疗费用影响的回顾性研究。
J Support Oncol. 2006 Jul-Aug;4(7):341-7.
7
Skeletal metastases in non-small cell lung cancer: a retrospective study.非小细胞肺癌骨转移:一项回顾性研究。
Lung Cancer. 2007 Aug;57(2):229-32. doi: 10.1016/j.lungcan.2007.03.013. Epub 2007 Apr 23.
8
Long bone metastases as predictors of survival in patients with metastatic renal cancer.长骨转移作为转移性肾癌患者生存的预测指标。
Nucl Med Rev Cent East Eur. 2015;18(2):89-91. doi: 10.5603/NMR.2015.0021.
9
Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark.丹麦基于人群的队列研究:乳腺癌患者骨转移和骨骼相关事件的发生率。
BMC Cancer. 2011 Jan 24;11:29. doi: 10.1186/1471-2407-11-29.
10
Healing flare in skeletal metastases from breast cancer.乳腺癌骨转移中的愈合性耀斑。
Radiology. 1994 Jul;192(1):201-4. doi: 10.1148/radiology.192.1.8208938.

引用本文的文献

1
Do metastatic volumes measured in breast cancer patients with bone metastases correlate with the numbers of skeletal and extraskeletal events?骨转移乳腺癌患者的转移瘤体积与骨骼和骨骼外事件的数量是否相关?
Jt Dis Relat Surg. 2024 Jan 1;35(1):105-111. doi: 10.52312/jdrs.2023.1333. Epub 2023 Nov 2.
2
Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers.接受骨修饰剂治疗乳腺癌和去势抵抗性前列腺癌骨转移的患者中,与骨骼相关的症状性事件。
Support Care Cancer. 2022 May;30(5):3977-3984. doi: 10.1007/s00520-021-06714-8. Epub 2022 Jan 21.
3
Incidence, prognosis and nomograms of breast cancer with bone metastases at initial diagnosis: a large population-based study.
初诊时伴有骨转移的乳腺癌的发病率、预后及列线图:一项基于大人群的研究
Am J Transl Res. 2021 Sep 15;13(9):10248-10261. eCollection 2021.
4
Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey.乳腺癌和前列腺癌骨转移患者中骨改良药物降阶梯治疗的真实世界实践模式及态度:一项医师调查
J Bone Oncol. 2020 Nov 10;26:100339. doi: 10.1016/j.jbo.2020.100339. eCollection 2021 Feb.
5
Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data.乳腺癌患者骨转移和骨相关事件(SREs)的发病率、危险因素及预后特征:基于真实世界数据的系统评价
J Bone Oncol. 2018 Feb 3;11:38-50. doi: 10.1016/j.jbo.2018.01.004. eCollection 2018 Jun.